ID   EPHA6_HUMAN             Reviewed;        1035 AA.
AC   Q9UF33;
DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2006, sequence version 2.
DT   02-NOV-2010, entry version 79.
DE   RecName: Full=Ephrin type-A receptor 6;
DE            EC=2.7.10.1;
DE   AltName: Full=EPH homology kinase 2;
DE            Short=EHK-2;
DE   Flags: Precursor;
GN   Name=EPHA6; Synonyms=EHK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=14726470; DOI=10.1373/clinchem.2003.026849;
RA   Hafner C., Schmitz G., Meyer S., Bataille F., Hau P., Langmann T.,
RA   Dietmaier W., Landthaler M., Vogt T.;
RT   "Differential gene expression of Eph receptors and ephrins in benign
RT   human tissues and cancers.";
RL   Clin. Chem. 50:490-499(2004).
RN   [4]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-703.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor for members of the ephrin-A family.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UF33-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UF33-2; Sequence=VSP_018473, VSP_018474, VSP_018475,
CC                                  VSP_018476;
CC   -!- TISSUE SPECIFICITY: Expressed in brain and testis.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Ephrin receptor subfamily.
CC   -!- SIMILARITY: Contains 2 fibronectin type-III domains.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SAM (sterile alpha motif) domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133666; CAB63775.1; -; mRNA.
DR   EMBL; AC109782; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC119745; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC107482; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC117470; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC130510; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC117439; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   IPI; IPI00737817; -.
DR   IPI; IPI00783604; -.
DR   PIR; T43450; T43450.
DR   RefSeq; NP_775926.1; -.
DR   UniGene; Hs.653244; -.
DR   ProteinModelPortal; Q9UF33; -.
DR   SMR; Q9UF33; 33-207, 273-299, 451-537, 617-937, 957-1029.
DR   STRING; Q9UF33; -.
DR   PhosphoSite; Q9UF33; -.
DR   PRIDE; Q9UF33; -.
DR   Ensembl; ENST00000389672; ENSP00000374323; ENSG00000080224.
DR   Ensembl; ENST00000477384; ENSP00000419470; ENSG00000080224.
DR   GeneID; 285220; -.
DR   UCSC; uc003drr.2; human.
DR   UCSC; uc010how.1; human.
DR   CTD; 285220; -.
DR   GeneCards; GC03P096533; -.
DR   HGNC; HGNC:19296; EPHA6.
DR   MIM; 600066; gene.
DR   PharmGKB; PA134866684; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG062180; -.
DR   InParanoid; Q9UF33; -.
DR   BRENDA; 2.7.10.1; 247.
DR   Pathway_Interaction_DB; epha_fwdpathway; EPHA forward signaling.
DR   Pathway_Interaction_DB; ephrina_ephapathway; EphrinA-EPHA pathway.
DR   NextBio; 95357; -.
DR   ArrayExpress; Q9UF33; -.
DR   Bgee; Q9UF33; -.
DR   CleanEx; HS_EPHA6; -.
DR   Genevestigator; Q9UF33; -.
DR   GermOnline; ENSG00000080224; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005003; F:ephrin receptor activity; IEA:InterPro.
DR   GO; GO:0005515; F:protein binding; IEA:InterPro.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kin...; IEA:InterPro.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd.
DR   InterPro; IPR008957; Fibronectin_III_dom.
DR   InterPro; IPR003961; FN_III.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR009030; Growth_fac_rcpt.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM_type.
DR   InterPro; IPR021129; SAM_type1.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR010993; Sterile_alpha_motif_homology.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   InterPro; IPR020768; Tyr_prot_kinase_EphA_rcpt.
DR   InterPro; IPR016257; Tyr_prot_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_prot_kinase_rcpt_V_CS.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 2.
DR   Gene3D; G3DSA:1.10.150.50; SAM_type; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   PANTHER; PTHR23256:SF278; Tyr_prot_kinase_EphA_rcpt; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07714; Pkinase_Tyr; 2.
DR   Pfam; PF00536; SAM_1; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00454; SAM; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF49265; FN_III-like; 2.
DR   SUPFAM; SSF49785; Gal_bind_like; 1.
DR   SUPFAM; SSF57184; Grow_fac_recept; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF47769; SAM_homology; 1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; ATP-binding; Complete proteome; Glycoprotein;
KW   Kinase; Membrane; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Receptor; Repeat; Signal; Transferase; Transmembrane;
KW   Transmembrane helix; Tyrosine-protein kinase.
FT   SIGNAL        1     22       Potential.
FT   CHAIN        23   1035       Ephrin type-A receptor 6.
FT                                /FTId=PRO_0000235684.
FT   TOPO_DOM     23    549       Extracellular (Potential).
FT   TRANSMEM    550    570       Helical; (Potential).
FT   TOPO_DOM    571   1035       Cytoplasmic (Potential).
FT   DOMAIN      330    434       Fibronectin type-III 1.
FT   DOMAIN      438    533       Fibronectin type-III 2.
FT   DOMAIN      630    943       Protein kinase.
FT   DOMAIN      960   1024       SAM.
FT   NP_BIND     636    644       ATP (By similarity).
FT   REGION       33    206       Ephrin-binding.
FT   MOTIF      1033   1035       PDZ-binding (Potential).
FT   ACT_SITE    797    797       Proton acceptor (By similarity).
FT   BINDING     662    662       ATP (By similarity).
FT   MOD_RES     605    605       Phosphotyrosine; by autocatalysis
FT                                (Potential).
FT   MOD_RES     611    611       Phosphotyrosine; by autocatalysis
FT                                (Potential).
FT   MOD_RES     830    830       Phosphotyrosine; by autocatalysis
FT                                (Potential).
FT   MOD_RES     977    977       Phosphotyrosine; by autocatalysis
FT                                (Potential).
FT   CARBOHYD    342    342       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    396    396       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    409    409       N-linked (GlcNAc...) (Potential).
FT   VAR_SEQ       1    513       Missing (in isoform 2).
FT                                /FTId=VSP_018473.
FT   VAR_SEQ     514    536       IRVRTATGYSGYSQKFEFETGDE -> MKDSPFQVTKLYWL
FT                                NEKWDFIAS (in isoform 2).
FT                                /FTId=VSP_018474.
FT   VAR_SEQ     834    847       GGKIPIRWTAPEAI -> DLFQTLTLNLCYSA (in
FT                                isoform 2).
FT                                /FTId=VSP_018475.
FT   VAR_SEQ     848   1035       Missing (in isoform 2).
FT                                /FTId=VSP_018476.
FT   VARIANT     703    703       F -> S.
FT                                /FTId=VAR_042149.
FT   VARIANT     710    710       A -> V (in dbSNP:rs4857276).
FT                                /FTId=VAR_055991.
FT   CONFLICT    597    598       CK -> LR (in Ref. 1; CAB63775).
FT   CONFLICT    701    701       S -> R (in Ref. 1; CAB63775).
SQ   SEQUENCE   1035 AA;  116116 MW;  4D58757D9F4CF178 CRC64;
     MGGCEVREFL LQFGFFLPLL TAWPGDCSHV SNQVVLLDTT TVLGELGWKT YPLNGWDAIT
     EMDEHNRPIH TYQVCNVMEP NQNNWLRTNW ISRDAAQKIY VEMKFTLRDC NSIPWVLGTC
     KETFNLFYME SDESHGIKFK PNQYTKIDTI AADESFTQMD LGDRILKLNT EIREVGPIER
     KGFYLAFQDI GACIALVSVR VFYKKCPFTV RNLAMFPDTI PRVDSSSLVE VRGSCVKSAE
     ERDTPKLYCG ADGDWLVPLG RCICSTGYEE IEGSCHACRP GFYKAFAGNT KCSKCPPHSL
     TYMEATSVCQ CEKGYFRAEK DPPSMACTGP PSAPRNVVFN INETALILEW SPPSDTGGRK
     DLTYSVICKK CGLDTSQCED CGGGLRFIPR HTGLINNSVI VLDFVSHVNY TFEIEAMNGV
     SELSFSPKPF TAITVTTDHD APSLIGMMRK DWASQNSIAL SWQAPAFSNG AILDYEIKYY
     EKEHEQLTYS STRSKAPSVI ITGLKPATKY VFHIRVRTAT GYSGYSQKFE FETGDEASDM
     AAEQGQILVI ATAAVGGFTL LVILTLFFLI TGRCQWYIKA KMKSEEKRRN HLQNGHCKFP
     GIKTYIDPDT YEDPSLAVHE FAKEIDPSRI RIERVIGAGE FGEVCSGRLK TPGKREIPVA
     IKTLKGGHMD RQRRDFLREA SIMGQFDHPN IIRLEGVVTK SSFPAIGVEA FCPSFLRAGF
     LNSIQAPHPV PGGGSLPPRI PAGRPVMIVV EYMENGSLDS FLRKHDGHFT VIQLVGMLRG
     IASGMKYLSD MGYVHRDLAA RNILVNSNLV CKVSDFGLSR VLEDDPEAAY TTTGGKIPIR
     WTAPEAIAYR KFSSASDAWS YGIVMWEVMS YGERPYWEMS NQDVILSIEE GYRLPAPMGC
     PASLHQLMLH CWQKERNHRP KFTDIVSFLD KLIRNPSALH TLVEDILVMP ESPGEVPEYP
     LFVTVGDWLD SIKMGQYKNN FVAAGFTTFD LISRMSIEDI RRIGVILIGH QRRIVSSIQT
     LRLHMMHIQE KGFHV
//
